Literature DB >> 11746459

Bulbus arteriosus of the bivalve mollusc Mercenaria mercenaria: Morphology and pharmacology.

L E Deaton1, B E Felgenhauer, D W Duhon.   

Abstract

We examined the morphology and pharmacology of the bulbus arteriosus of the marine bivalve mollusc Mercenaria mercenaria. The bulbus arteriosus is an organ of unknown function associated with the posterior aorta and the ventricle. It is composed of connective tissue interspersed with muscle bundles. In contrast to the lumen of the ventricle, which has an extensive trabecular network, the lumen of the bulbus arteriosus has no trabeculae. No valve is present in the posterior aorta connecting the lumina of the ventricle and the bulbus arteriosus. Scattered neuronal profiles are present in the wall and the axonal processes contain vesicles that may contain neurosecretory products. We did not, however, find synapses or evidence of vesicular release into the lumen of the bulbus arteriosus. The bulbus arteriosus contains acetylcholine, 5-hydroxytryptamine (5HT), and the molluscan neuropeptides FMRFamide (phenyl-alanyl-methionyl-arginyl-phenylalaninylamide) and FLRFamide (phenylalanyl-leucinyl-arginyl-phenylalanylamide). The isolated bulbus arteriosus contracts tonically in response to mechanical stress and exposure to 5HT or FMRFamide, while acetylcholine relaxes it. We surmise that the bulbus arteriosus probably functions as a mechanism for regulating the relative amounts of hemolymph pumped into the anterior and posterior aortae by the ventricle and that the bulbus arteriosus may be a neurohemal site. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746459     DOI: 10.1002/jmor.1064

Source DB:  PubMed          Journal:  J Morphol        ISSN: 0022-2887            Impact factor:   1.804


  1 in total

1.  Physiological-biochemical properties of blue mussel Mytilus edulis adaptation to oil contamination.

Authors:  Igor N Bakhmet; Natalia N Fokina; Zinaida A Nefedova; Nina N Nemova
Journal:  Environ Monit Assess       Date:  2008-08-17       Impact factor: 2.513

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.